ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Fundamental Analysis & Valuation

OSL:AZT • NO0010014632

Current stock price

20.9 NOK
-0.6 (-2.79%)
Last:

This AZT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. AZT.OL Profitability Analysis

1.1 Basic Checks

  • In the past year AZT was profitable.
  • In the past year AZT had a positive cash flow from operations.
  • Each year in the past 5 years AZT has been profitable.
  • In the past 5 years AZT always reported a positive cash flow from operatings.
AZT.OL Yearly Net Income VS EBIT VS OCF VS FCFAZT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

  • AZT has a better Return On Assets (2.86%) than 74.07% of its industry peers.
  • AZT's Return On Equity of 3.05% is fine compared to the rest of the industry. AZT outperforms 75.31% of its industry peers.
  • With a decent Return On Invested Capital value of 0.66%, AZT is doing good in the industry, outperforming 74.07% of the companies in the same industry.
Industry RankSector Rank
ROA 2.86%
ROE 3.05%
ROIC 0.66%
ROA(3y)3.64%
ROA(5y)7.51%
ROE(3y)3.94%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
AZT.OL Yearly ROA, ROE, ROICAZT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.18%, AZT is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AZT has declined.
  • The Operating Margin of AZT (2.50%) is better than 72.84% of its industry peers.
  • In the last couple of years the Operating Margin of AZT has declined.
  • With an excellent Gross Margin value of 95.84%, AZT belongs to the best of the industry, outperforming 91.36% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AZT has remained more or less at the same level.
Industry RankSector Rank
OM 2.5%
PM (TTM) 9.18%
GM 95.84%
OM growth 3Y-54.57%
OM growth 5Y-44.12%
PM growth 3Y-28.49%
PM growth 5Y-37.08%
GM growth 3Y-0.13%
GM growth 5Y-0.6%
AZT.OL Yearly Profit, Operating, Gross MarginsAZT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AZT.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AZT is destroying value.
  • The number of shares outstanding for AZT remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, AZT has more shares outstanding
  • AZT has a better debt/assets ratio than last year.
AZT.OL Yearly Shares OutstandingAZT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
AZT.OL Yearly Total Debt VS Total AssetsAZT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • AZT has an Altman-Z score of 30.10. This indicates that AZT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 30.10, AZT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • AZT has a debt to FCF ratio of 0.24. This is a very positive value and a sign of high solvency as it would only need 0.24 years to pay back of all of its debts.
  • The Debt to FCF ratio of AZT (0.24) is better than 93.83% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that AZT is not too dependend on debt financing.
  • The Debt to Equity ratio of AZT (0.01) is better than 80.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.24
Altman-Z 30.1
ROIC/WACC0.08
WACC8.54%
AZT.OL Yearly LT Debt VS Equity VS FCFAZT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • AZT has a Current Ratio of 16.39. This indicates that AZT is financially healthy and has no problem in meeting its short term obligations.
  • AZT has a better Current ratio (16.39) than 96.30% of its industry peers.
  • AZT has a Quick Ratio of 15.53. This indicates that AZT is financially healthy and has no problem in meeting its short term obligations.
  • AZT has a Quick ratio of 15.53. This is amongst the best in the industry. AZT outperforms 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 16.39
Quick Ratio 15.53
AZT.OL Yearly Current Assets VS Current LiabilitesAZT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AZT.OL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.71% over the past year.
  • AZT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -34.95% yearly.
  • The Revenue has been growing slightly by 7.92% in the past year.
  • Measured over the past years, AZT shows a small growth in Revenue. The Revenue has been growing by 3.80% on average per year.
EPS 1Y (TTM)35.71%
EPS 3Y-33.29%
EPS 5Y-34.95%
EPS Q2Q%116.67%
Revenue 1Y (TTM)7.92%
Revenue growth 3Y-6.32%
Revenue growth 5Y3.8%
Sales Q2Q%31.1%

3.2 Future

  • AZT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 74.81% yearly.
  • Based on estimates for the next years, AZT will show a very strong growth in Revenue. The Revenue will grow by 35.40% on average per year.
EPS Next Y117.95%
EPS Next 2Y92.21%
EPS Next 3Y74.81%
EPS Next 5YN/A
Revenue Next Year26.73%
Revenue Next 2Y22.57%
Revenue Next 3Y20.85%
Revenue Next 5Y35.4%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AZT.OL Yearly Revenue VS EstimatesAZT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
AZT.OL Yearly EPS VS EstimatesAZT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. AZT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 110.00 indicates a quite expensive valuation of AZT.
  • 72.84% of the companies in the same industry are more expensive than AZT, based on the Price/Earnings ratio.
  • AZT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.47.
  • A Price/Forward Earnings ratio of 50.47 indicates a quite expensive valuation of AZT.
  • Based on the Price/Forward Earnings ratio, AZT is valued a bit cheaper than the industry average as 75.31% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.62, AZT is valued quite expensively.
Industry RankSector Rank
PE 110
Fwd PE 50.47
AZT.OL Price Earnings VS Forward Price EarningsAZT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZT indicates a somewhat cheap valuation: AZT is cheaper than 70.37% of the companies listed in the same industry.
  • AZT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AZT is cheaper than 82.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 48.14
EV/EBITDA 76.53
AZT.OL Per share dataAZT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • AZT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AZT has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as AZT's earnings are expected to grow with 74.81% in the coming years.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y92.21%
EPS Next 3Y74.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AZT.OL Dividend Analysis

5.1 Amount

  • AZT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AZT.OL Fundamentals: All Metrics, Ratios and Statistics

ARCTICZYMES TECHNOLOGIES ASA

OSL:AZT (4/23/2026, 4:09:37 PM)

20.9

-0.6 (-2.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners14.7%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap1.07B
Revenue(TTM)112.62M
Net Income(TTM)10.34M
Analysts80
Price Target34.68 (65.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)102.97%
Min EPS beat(2)48.51%
Max EPS beat(2)157.43%
EPS beat(4)3
Avg EPS beat(4)33.31%
Min EPS beat(4)-269.73%
Max EPS beat(4)197.03%
EPS beat(8)4
Avg EPS beat(8)152.7%
EPS beat(12)6
Avg EPS beat(12)106.86%
EPS beat(16)7
Avg EPS beat(16)73.12%
Revenue beat(2)1
Avg Revenue beat(2)3.31%
Min Revenue beat(2)-5.88%
Max Revenue beat(2)12.5%
Revenue beat(4)2
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-13.1%
Max Revenue beat(4)12.5%
Revenue beat(8)3
Avg Revenue beat(8)-4.13%
Revenue beat(12)4
Avg Revenue beat(12)-5.44%
Revenue beat(16)5
Avg Revenue beat(16)-3.89%
PT rev (1m)0%
PT rev (3m)3.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.83%
Valuation
Industry RankSector Rank
PE 110
Fwd PE 50.47
P/S 9.48
P/FCF 48.14
P/OCF 41.35
P/B 3.15
P/tB 3.51
EV/EBITDA 76.53
EPS(TTM)0.19
EY0.91%
EPS(NY)0.41
Fwd EY1.98%
FCF(TTM)0.43
FCFY2.08%
OCF(TTM)0.51
OCFY2.42%
SpS2.21
BVpS6.63
TBVpS5.96
PEG (NY)0.93
PEG (5Y)N/A
Graham Number5.32284 (-74.53%)
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 3.05%
ROCE 0.82%
ROIC 0.66%
ROICexc 1.46%
ROICexgc 1.88%
OM 2.5%
PM (TTM) 9.18%
GM 95.84%
FCFM 19.69%
ROA(3y)3.64%
ROA(5y)7.51%
ROE(3y)3.94%
ROE(5y)8.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-70.15%
ROICexgc growth 5Y-48.7%
ROICexc growth 3Y-70.63%
ROICexc growth 5Y-51.12%
OM growth 3Y-54.57%
OM growth 5Y-44.12%
PM growth 3Y-28.49%
PM growth 5Y-37.08%
GM growth 3Y-0.13%
GM growth 5Y-0.6%
F-Score7
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.24
Debt/EBITDA 0.35
Cap/Depr 39.79%
Cap/Sales 3.23%
Interest Coverage 10.57
Cash Conversion 215.75%
Profit Quality 214.43%
Current Ratio 16.39
Quick Ratio 15.53
Altman-Z 30.1
F-Score7
WACC8.54%
ROIC/WACC0.08
Cap/Depr(3y)161.89%
Cap/Depr(5y)219.35%
Cap/Sales(3y)9.51%
Cap/Sales(5y)9.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y-33.29%
EPS 5Y-34.95%
EPS Q2Q%116.67%
EPS Next Y117.95%
EPS Next 2Y92.21%
EPS Next 3Y74.81%
EPS Next 5YN/A
Revenue 1Y (TTM)7.92%
Revenue growth 3Y-6.32%
Revenue growth 5Y3.8%
Sales Q2Q%31.1%
Revenue Next Year26.73%
Revenue Next 2Y22.57%
Revenue Next 3Y20.85%
Revenue Next 5Y35.4%
EBIT growth 1Y295.28%
EBIT growth 3Y-57.44%
EBIT growth 5Y-41.99%
EBIT Next Year1933.33%
EBIT Next 3Y259.17%
EBIT Next 5YN/A
FCF growth 1Y381.95%
FCF growth 3Y-21.56%
FCF growth 5Y-13.13%
OCF growth 1Y1455.88%
OCF growth 3Y-23.81%
OCF growth 5Y-11.2%

ARCTICZYMES TECHNOLOGIES ASA / AZT.OL Fundamental Analysis FAQ

What is the fundamental rating for AZT stock?

ChartMill assigns a fundamental rating of 7 / 10 to AZT.OL.


What is the valuation status for AZT stock?

ChartMill assigns a valuation rating of 5 / 10 to ARCTICZYMES TECHNOLOGIES ASA (AZT.OL). This can be considered as Fairly Valued.


How profitable is ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) stock?

ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a profitability rating of 6 / 10.


What is the valuation of ARCTICZYMES TECHNOLOGIES ASA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 110 and the Price/Book (PB) ratio is 3.15.


How financially healthy is ARCTICZYMES TECHNOLOGIES ASA?

The financial health rating of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 9 / 10.